Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Business
Simon Hunt

FORGOTTEN HISTORY: Astrazeneca clears us regulatory hurdle for new cancer drug imfinzi | History Defined

Over 1,000 people are diagnosed with gallbladder cancer in the UK each year, according to Cancer Research

(Picture: PA Media)

Pharma giant AstraZeneca has cleared US regulatory hurdles to begin using its Imfinzi drug for the treatment of patients with gallbladder and bile duct cancer in a breakthrough for people with a rare but aggressive form of the disease.

Approval by the Food and Drug Administration follows final stage trials of the drug which showed it could reduce the risk of death by 20% compared with chemotherapy alone. Imfinzi is already approved in the US for treatment of lung cancer.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.